ArticleDermatology and therapy2026

Real-World Effectiveness and Safety of Bimekizumab for Moderate-to-Severe Hidradenitis Suppurativa: A Multicenter Retrospective Study from the Italian Landscape HS (IL-HS).

Mario Valenti et al.PubMed ↗Publisher ↗

No numbers read from the abstract.